A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)
A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)
Active, not recruiting · NCT07266090 · Registry updated 2026-07-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE) | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Active, not recruiting | Phase 2 | 2026-07-28 | NCT07266090 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Viatris Pharmaceuticals Co., Ltd. | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| First Affiliated Hospital of Henan University of Science and Technology | Luoyang | China | 1 |
| First Affiliated Hospital of Nanchang University | Nanchang | China | 1 |
| Jiujiang NO.1 peple's hospital | Jiujiang | China | 1 |
| Peking Union Medical College Hospital | Beijing | China | 1 |
| The First Affiliated Hospital of Jinan University | Guangzhou | China | 9 |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 125 |
| The Second Hospital of Hebei Medical University | Shijiazhuang | China | 30 |